Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-24139

Xla.Tg(Dre.gfap:mCherry-NTR) + MTZ, Edwards-Faret G et al. (2021)

Experiment + Assay: Xla.Tg(Dre.gfap:mCherry-NTR) + MTZ + NF50 (immunohistochemistry)
Background: Xla.Tg(Dre.gfap:mCherry-NTR)Larra
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
chemical metronidazole
NF stage 50 whole organism
Conditions:
Assay Type Assay Stages Antibody
immunohistochemistry NF stage 50  
Expression Phenotypes (1):
decreased amount sox2.L expression in spinal cord
Source: Fig. 7 K L
Article: XB-ART-57773, PubMed